403 related articles for article (PubMed ID: 25996046)
21. Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.
Pan R; Xu W; Ding Y; Lu S; Chen P
Mol Pharm; 2016 Apr; 13(4):1366-74. PubMed ID: 26937821
[TBL] [Abstract][Full Text] [Related]
22. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
[TBL] [Abstract][Full Text] [Related]
23. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
24. A cell-penetrating helical polymer for siRNA delivery to mammalian cells.
Gabrielson NP; Lu H; Yin L; Kim KH; Cheng J
Mol Ther; 2012 Aug; 20(8):1599-609. PubMed ID: 22643866
[TBL] [Abstract][Full Text] [Related]
25. Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines.
Deshayes S; Konate K; Rydström A; Crombez L; Godefroy C; Milhiet PE; Thomas A; Brasseur R; Aldrian G; Heitz F; Muñoz-Morris MA; Devoisselle JM; Divita G
Small; 2012 Jul; 8(14):2184-8. PubMed ID: 22514050
[No Abstract] [Full Text] [Related]
26. PTD/CPP peptide-mediated delivery of siRNAs.
Presente A; Dowdy SF
Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
[TBL] [Abstract][Full Text] [Related]
27. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
28. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
29. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
[TBL] [Abstract][Full Text] [Related]
30. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
31. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy.
Gessner I; Neundorf I
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268473
[TBL] [Abstract][Full Text] [Related]
33. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
34. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
[TBL] [Abstract][Full Text] [Related]
35. Cell-penetrating peptides for the delivery of nucleic acids.
Lehto T; Kurrikoff K; Langel Ü
Expert Opin Drug Deliv; 2012 Jul; 9(7):823-36. PubMed ID: 22594635
[TBL] [Abstract][Full Text] [Related]
36. Human-protein-derived peptides for intracellular delivery of biomolecules.
Haas AK; Maisel D; Adelmann J; von Schwerin C; Kahnt I; Brinkmann U
Biochem J; 2012 Mar; 442(3):583-93. PubMed ID: 22150630
[TBL] [Abstract][Full Text] [Related]
37. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
Tuttolomondo M; Ditzel HJ
Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
[TBL] [Abstract][Full Text] [Related]
38. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
39. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
Gooding M; Browne LP; Quinteiro FM; Selwood DL
Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
[TBL] [Abstract][Full Text] [Related]
40. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
